Metraipolis › archive › dc_07075fd782de
Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42597438
- DOI
- 10.3389/fnut.2026.1843743
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T07:19:25.056Z
- SHA-256 of the archived text
dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f- Stable URL of this page
https://metraipolis.com/documento/dc_07075fd782de
How to cite
Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438 — Europe PMC (en), https://europepmc.org/article/MED/42597438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07075fd782de (Metraipolis archive dc_07075fd782de, sha256 dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f)
BibTeX
@misc{dc07075fd782de,
title = {Assessment of blood cobalt levels and safety of long-term hydroxocobalamin therapy in patients with cblC defect — Europe PMC PMID:42597438},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42597438},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07075fd782de; sha256 dfb76216b167b36f1383331f7f1c05b2c164a28587071d128ba063222aa4260f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42597438. Agents can read the archived copy with the MCP tool read_document.